|
2024
|
Invention
|
Methods of treatment of metabolic disorders. METHODS OF TREATMENT OF METABOLIC DISORDERS In the p... |
|
|
Invention
|
A new relevant non-human animal model of progressive metabolic dysfunction-associated steatotic l... |
|
|
Invention
|
Systems and methods for tissue processing. Provided are closed systems methods of use for isolati... |
|
|
Invention
|
New clofoctol formulation. The invention concerns a new galenic formulation of CFT (clofoctol) al... |
|
|
Invention
|
Generating highly pure glutamatergic neuronal populations using the pro-neural factor ascl1. Glut... |
|
|
Invention
|
Conjugation of catechol containing siderophore with cargo molecules. The present disclosure relat... |
|
|
Invention
|
Indole-3-propionic acid as an important contributor to viral infection outcomes and a biomarker o... |
|
2023
|
Invention
|
Single-domain antibody targeting von wilebrand factor a3-domain. Inventors have isolated a single... |
|
|
Invention
|
Image-based high-content screening methods for identifying compounds targeting apicomplexan paras... |
|
|
Invention
|
Blastocystis sp. as a predictive biomarker of high productive longevity in dairy heifers. Blastoc... |
|
|
Invention
|
Use of bordetella strains for the treatment of chronic obstructive pulmonary disease. Chronic obs... |
|
|
Invention
|
Mutant bordetella strains and methods of use.
A method of reducing or preventing the development... |
|
|
Invention
|
Tricyclic spirolactam compounds with antimycobacterial activity. tuberculosistuberculosis. |
|
|
Invention
|
O-glcnacase inhibition as a treatment for acute decompensated heart failure. Exacerbation of hear... |
|
|
Invention
|
Treatment of acute respiratory distress syndrome (ards) in a patient. The invention relates to ES... |
|
|
Invention
|
Influenza vaccine, composition, and methods of use.
The invention relates to compositions and va... |
|
|
Invention
|
Hepatitis e virus orf2 capsid polypeptides and uses thereof.
Hepatitis E virus (HEV) is responsi... |
|
|
Invention
|
Benzothiazole anaologues and use thereof as boosters of anti tuberculosis drugs. The present inve... |
|
2022
|
Invention
|
Bordetella strains expressing serotype 3 fimbriae.
A Fim3-producing BPZE1 derivative with suffic... |
|
|
Invention
|
Novel pneumococcal polypeptide antigens. Streptococcuspneumoniaepneumoniae. |
|
|
Invention
|
Gram-negative bacteria efflux pump inhibitors.
The present invention concerns novel Gram-negativ... |
|
|
Invention
|
Gram-negative bacteria efflux pump inhibitors. The present invention concerns novel Gram-negative... |
|
|
Invention
|
Aerosol composition for pulmonary delivery of flagellin.
The present invention arises from a for... |
|
|
Invention
|
Aerosol composition for pulmonary delivery of flagellin. The present invention arises from a form... |
|
|
Invention
|
Use of clofoctol for the treatment of inflammation.
There is a need for novel therapies for the ... |
|
|
Invention
|
Use of clofoctol for the treatment of inflammation. There is a need for novel therapies for the t... |
|
|
Invention
|
Use of a compound such as plerixafor for treating a viral pulmonary disease.
A compound of formu... |
|
|
Invention
|
Use of a compound such as plerixafor for treating a viral pulmonary disease. The present inventio... |
|
|
Invention
|
Attenuated bordetella strains.
A mutated Bordetella strain comprising at least a mutated ptx gen... |
|
2021
|
Invention
|
Erap inhibitors.
The present disclosure relates to novel compounds of formula (I) which are usef... |
|
|
Invention
|
Erap inhibitors. The present disclosure relates to novel compounds of formula (I) which are usefu... |
|
|
Invention
|
Device for optical imaging of arthropods. Device (1) for optical imaging of at least one arthropo... |
|
|
Invention
|
Modular system and process for individualized accommodation, feeding and monitoring of arthropods... |
|
|
Invention
|
Parabacteroides distasonis strains for use thereof in the treatment and prevention of gastrointes... |
|
|
Invention
|
Vaccine for prophylaxis or treatment of an allergen-driven airway pathology. pertussis toxin (PTX... |
|
|
Invention
|
Method to treat a pathogen lung infection. The present invention relates to the treatment of path... |
|
|
Invention
|
Use of tmprss2 inhibitors for the treatment of lung viral infections. In December 2019, a new cor... |
|
|
Invention
|
New compositions and methods of treating covid-19 disease.
A method of treating COVID-19 in a pa... |
|
|
Invention
|
New compositions and methods of treating covid-19 disease. The present invention relates novel co... |
|
|
Invention
|
Use of sulconazole compounds for the treatment of coronavirus infections. In December 2019, a new... |
|
2020
|
Invention
|
Use of retinoic acid receptor (rar) agonists for reversing, preventing, or delaying calcification... |
|
|
Invention
|
Antibodies specific for il20-rb and uses thereof for the treatment of acute exacerbation of chron... |
|
|
Invention
|
Use of materials made of cross-linked beta-cyclodextrins for the treatment of tuberculosis.
Mult... |
|
|
Invention
|
5-membered heteroaryl compounds containing a hydroxamate moiety and their use.
The present inven... |
|
2019
|
Invention
|
Use of antagonists of th17 cytokines for the treatment of bronchial remodeling in patients suffer... |
|
|
Invention
|
Antibodies having specificity for the orf2i protein of hepatitis e virus and uses thereof for dia... |
|
2018
|
Invention
|
Pyropheophorbide conjugate and use thereof in the treatment of cancer and as a fluorescent marker... |
|
|
P/S
|
Sales administration; Distribution of advertising, marketing and promotional material; Disseminat... |
